Mind Body Therapy for the Treatment of Chronic Pain
1 other identifier
interventional
35
1 country
1
Brief Summary
Chronic pain syndromes without identified organic etiology remain a challenge for physicians. Many syndromes, including back pain, are believed to have potential underlying psychological etiology; however, the exact link remains elusive. The goal of this study is to determine if mind body therapies can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of Mind Body Syndrome Therapy (MBST) in reducing disability from back pain and alleviating back pain. The investigators will secondarily investigate whether MBST can improve participant quality of life and reduce the need for pain-related hospitalization. The design of the this study consists of 3 arms with one being the intervention (MBST), one being usual care, and one being a second mind-body intervention (active control). This education program consists of a series of personal interviews and group and/or individualized lectures/sessions. Participants will also be provided reading material to study during the intervention period, and asked to continue their usual care while going through the MBST program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-pain
Started Jul 2019
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2019
CompletedStudy Start
First participant enrolled
July 30, 2019
CompletedFirst Posted
Study publicly available on registry
July 31, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2020
CompletedJanuary 11, 2023
January 1, 2023
9 months
July 29, 2019
January 10, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Pain Disability: Roland Morris Disability Index
Change in the Roland Morris Disability Index (Scale 0-24 with 24 being worst)
change over 26 weeks
Secondary Outcomes (7)
Average Pain: Brief Pain Inventory Survey
4 weeks, 8 weeks, 13, weeks, 26 weeks
Pain Bothersomeness (Back Specific): Brief Pain Inventory Survey
4 weeks, 8 weeks, 13 weeks, 26 weeks
Pain Bothersomeness: Brief Pain Inventory Survey
4 weeks, 8 weeks, 13 weeks, 26 weeks
Pain affecting enjoyment of life
4 weeks, 8 weeks, 13 weeks, 26 weeks
Anxiety from pain: Pain Anxiety Symptom Scale-20 survey
4 weeks, 8 weeks, 13 weeks, 26 weeks
- +2 more secondary outcomes
Study Arms (3)
Usual Care
NO INTERVENTIONParticipants will continue their usual care for 26 weeks
Mind Body Intervention 1: Mind-Body-Syndrome-Therapy (MBST)
EXPERIMENTALParticipants will receive a mind body educational-based intervention to learn the techniques comprising intervention 1. Further details are not provided for blinding purposes.
Mind Body Intervention 2
ACTIVE COMPARATORParticipants will receive a mind-body educational-based intervention to learn the techniques comprising intervention 2. Further details are not provided for blinding purposes.
Interventions
Mind body techniques for Intervention 1 will be taught in lectures and group discussion sessions.
Mind body techniques for Intervention 2 will be taught in lectures and group and/or individual sessions.
Eligibility Criteria
You may qualify if:
- Adult patient 18 \> years old
- Chronic back pain
- Pain persistent for ≥3 days/week for the past 3 months prior to enrollment
- Willingness to consider mind-body intervention
You may not qualify if:
- Patients \< 18 years of age
- Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia, dementia and bipolar disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Donnino, MD
Beth Israel Deaconess Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will be partially blinded. Participants in the usual care arm will be blinded to the specifics of the interventions. Intervention participants will be blinded to the specifics of the intervention until after they have been randomized into that arm. Data analysis will be conducted by persons who are completely blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Emergency Medicine
Study Record Dates
First Submitted
July 29, 2019
First Posted
July 31, 2019
Study Start
July 30, 2019
Primary Completion
April 20, 2020
Study Completion
April 20, 2020
Last Updated
January 11, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share
The investigators will not be sharing IPD data with researchers outside of their research group.